285 related articles for article (PubMed ID: 26026694)
1. Diagnosis and monitoring of IgA nephropathy: the role of biomarkers as an alternative to renal biopsy.
Moresco RN; Speeckaert MM; Delanghe JR
Autoimmun Rev; 2015 Oct; 14(10):847-53. PubMed ID: 26026694
[TBL] [Abstract][Full Text] [Related]
2. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
Novak J; Julian BA; Tomana M; Mestecky J
Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
[TBL] [Abstract][Full Text] [Related]
3. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis.
Suzuki H
Clin Exp Nephrol; 2019 Jan; 23(1):26-31. PubMed ID: 29740706
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
Novak J; Julian BA; Mestecky J; Renfrow MB
Semin Immunopathol; 2012 May; 34(3):365-82. PubMed ID: 22434325
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and classification of IgA nephropathy.
Yu HH; Chiang BL
Autoimmun Rev; 2014; 13(4-5):556-9. PubMed ID: 24434362
[TBL] [Abstract][Full Text] [Related]
10. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
11. IgA nephropathy enigma.
Mestecky J; Novak J; Moldoveanu Z; Raska M
Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
[TBL] [Abstract][Full Text] [Related]
12. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
Suzuki Y; Suzuki H; Yasutake J; Tomino Y
Expert Opin Biol Ther; 2015 Apr; 15(4):583-93. PubMed ID: 25604055
[TBL] [Abstract][Full Text] [Related]
13. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
15. Markers for the progression of IgA nephropathy.
Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of IgA receptors in IgA nephropathy.
Monteiro RC
Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights into the Pathogenesis of IgA Nephropathy.
Robert T; Berthelot L; Cambier A; Rondeau E; Monteiro RC
Trends Mol Med; 2015 Dec; 21(12):762-775. PubMed ID: 26614735
[TBL] [Abstract][Full Text] [Related]
20. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
